Globus Medical, Inc. 10-Q filed Nov 5, 2026

Modified

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes that appear in Part I, Item 1 of this Quarterly Report on Form 10-Q (this “Quarterly Report”) and with our audited consolidated financial statements and related notes for the year ended December 31, 2025, which are included in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the United States (“U.S.”) Securities and Exchange Commission (the “SEC”) on February 24, 2026. This “Management’s Discussion and Analysis of Financial Condition and Results of Operations” generally discusses the three and sixnine months ended JuneSeptember 30, 2026 and 2025 and provides comparisons between the periods. A discussion of our Results of Operations for the three and sixnine months ended JuneSeptember 30, 2025, can be found in “Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations: Results of Operations; Three Months Ended JuneSeptember 30, 2025 Compared to the Three Months Ended JuneSeptember 30, 2024” and “Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations: Results of Operations; SixNine Months Ended JuneSeptember 30, 2025 Compared to the SixNine Months Ended JuneSeptember 30, 2024 ” in our Quarterly Report on Form 10-Q for the quarter ended JuneSeptember 30, 2025 filed with the SEC on August 7November 6, 2025.